Skip to main content
. 2013 Aug 13;54(8):5416–5423. doi: 10.1167/iovs.13-11853

Figure 2.

Figure 2

In vitro biocompatibility test using newly generated, stably eGFP-expressing cell lines (CrFK, fibroblasts; NTM, trabecular meshwork cells; BCE, endothelial cells; N = 3). Because shunts are not translucent, a reflection-based fluorescence assay had to be developed. (A) Example of transduced CrFK cells on GS. Graphic representations of cell growth rates on days 2 through 5 after seeding on GS (B) and PS (C).